These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 14601057)

  • 21. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
    Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
    Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter CpG island hypermethylation during breast cancer progression.
    Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls.
    Locke I; Kote-Jarai Z; Fackler MJ; Bancroft E; Osin P; Nerurkar A; Izatt L; Pichert G; Gui GP; Eeles RA
    Breast Cancer Res; 2007; 9(1):R20. PubMed ID: 17324252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a low-grade precursor pathway in breast cancer?
    King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes.
    Van der Auwera I; Bovie C; Svensson C; Limame R; Trinh XB; van Dam P; Van Laere SJ; Van Marck E; Vermeulen PB; Dirix LY
    Cancer Biol Ther; 2009 Dec; 8(23):2252-9. PubMed ID: 19829046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
    Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
    Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
    Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP
    Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologcial and clonal study of combined lobular and ductal carcinoma of the breast.
    Tazaki E; Shishido-Hara Y; Mizutani N; Nomura S; Isaka H; Ito H; Imi K; Imoto S; Kamma H
    Pathol Int; 2013 Jun; 63(6):297-304. PubMed ID: 23782331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
    Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
    BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
    Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
    Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
    Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
    Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.
    Seniski GG; Camargo AA; Ierardi DF; Ramos EA; Grochoski M; Ribeiro ES; Cavalli IJ; Pedrosa FO; de Souza EM; Zanata SM; Costa FF; Klassen G
    BMC Cancer; 2009 Mar; 9():80. PubMed ID: 19267929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
    Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk.
    Euhus DM; Bu D; Ashfaq R; Xie XJ; Bian A; Leitch AM; Lewis CM
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1812-21. PubMed ID: 17855699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Kweon SS; Fackler MJ; Sukumar S
    Virchows Arch; 2010 Jul; 457(1):35-42. PubMed ID: 20496080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.